Dassil Pharmaceutical Private Limited
About Dassil Pharmaceutical Private Limited
Data last updated:
Dassil Pharmaceutical Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2015PTC208488.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Papia Sil and Suparna Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101/5 Amritalal Mukherjee Road P.O. – Thakurpukur, Kolkata, West Bengal, India – 700063.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.71 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹2.36 Lakh (net margin -15%) and EBITDA of -₹1.42 Lakh (EBITDA margin -9%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address101/5 Amritalal Mukherjee Road P.O. – Thakurpukur, Kolkata, West Bengal, India – 700063
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dassil Pharmaceutical Private Limited
The main business activity of Dassil Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dassil Pharmaceutical Private Limited FY 2025 filings available
Dassil Pharmaceutical Private Limited reported revenue of ₹15.71 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dassil Pharmaceutical Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 6% fall in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dassil Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.42 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dassil Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -15% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dassil Pharmaceutical are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dassil Pharmaceutical Private Limited
Dassil Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Papia Sil | Director | 18 Nov 2015 | 10 Years 11 Months | Current |
| Suparna Das | Director | 18 Nov 2015 | 10 Years 11 Months | Current |
Peer Comparison of Dassil Pharmaceutical Private Limited
Dassil Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ams Specialities Private Limited | ₹15.79 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Triveni Pesticides Private Limited | ₹15.74 Lakh (FY 2019) | •••• | •••• | -63.0% | •••• | Jaipur, Rajasthan, India |
| Infinite Herbal Solutions Private Limited | ₹15.72 Lakh (FY 2024) | •••• | •••• | 86.0% | •••• | Jhajjar, Haryana, India |
| Windson Healthcare & Pharmaceutical Private Limited | ₹15.71 Lakh (FY 2019) | •••• | •••• | 170.0% | •••• | New Delhi, Delhi, India |
| Sudh Biochem Private Limited | ₹15.71 Lakh (FY 2025) | •••• | •••• | 307.0% | •••• | Kalyani, West Bengal, India |
| Dassil Pharmaceutical Private Limited this company | ₹15.71 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Kolkata, West Bengal, India |
| Cultigen Organics Private Limited | ₹15.7 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Hyderabad, Telangana, India |
| Lakshit Chemical Private Limited | ₹15.7 Lakh (FY 2024) | •••• | •••• | -78.0% | •••• | Karnal, Haryana, India |
| Ambervet Synthetics Private Limited | ₹15.67 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Pune, Maharashtra, India |
| P C I Chemicals Pvt Ltd | ₹15.67 Lakh (FY 2019) | •••• | •••• | -39.0% | •••• | Kolkata, West Bengal, India |
| Suvirs Sales Private Limited | ₹15.66 Lakh (FY 2025) | •••• | •••• | -50.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Dassil Pharmaceutical by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dassil Pharmaceutical Private Limited
Dassil Pharmaceutical Private Limited is audited by SUVANKAR HALDAR & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUVANKAR HALDAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dassil Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dassil Pharmaceutical Private Limited
Dassil Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dassil Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Dassil Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dassil Pharmaceutical Private Limited
Dassil Pharmaceutical Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Papia Sil was appointed as Director on 18 Nov 2015.
Credit Ratings, Litigation & Regulatory Alerts for Dassil Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dassil Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dassil Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dassil Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dassil Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dassil Pharmaceutical Private Limited
Dassil Pharmaceutical is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 November 2015 (11+ years old) and is registered under CIN U24100WB2015PTC208488.
Dassil Pharmaceutical reported revenue of ₹15.71 Lakh for FY 2025 (down 6% YoY).
Dassil Pharmaceutical has 2 current directors:
- Papia Sil - Director
- Suparna Das - Director
Dassil Pharmaceutical reported a net loss of ₹2.36 Lakh (net margin -15%) and EBITDA of -₹1.42 Lakh (EBITDA margin -9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dassil Pharmaceutical is -18% over three years and -12% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Dassil Pharmaceutical is U24100WB2015PTC208488. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dassil Pharmaceutical was incorporated on 18 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Dassil Pharmaceutical by revenue are Ams Specialities Private Limited, Triveni Pesticides Private Limited, Infinite Herbal Solutions Private Limited, Windson Healthcare & Pharmaceutical Private Limited, Sudh Biochem Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Papia Sil was appointed as Director on 18 Nov 2015. Suparna Das was appointed as Director on 18 Nov 2015.
The registered office of Dassil Pharmaceutical is at 1015 Amritalal Mukherjee Road P.O. – Thakurpukur, Kolkata, West Bengal, India – 700063.
Dassil Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.